3 Results for "

hPPARα

" in MedChemExpress (MCE) Product Catalog:
Products (3)

3 Results for "hPPARα" in MCE Product Catalog:

Cat. No.: HY-106181
CAS No.: 185428-18-6
Purity:  98.59%
Synonyms: R-106056
Target:  

PPAR

Rivoglitazone (R-106056) is an orally active, selective PPARγ agonist with an EC50 of 0.22 μM for hPPARγ. Rivoglitazone regulates fatty acid storage and uptake, glucose homeostasis, and cardiac glucose/fatty acid metabolism. Rivoglitazone reduces levels of hyperglycemia, hyperinsulinemia, and hypertriglyceridemia, decreases hepatic glucose production, and accelerates plasma triglyceride clearance. Rivoglitazone induces a reduction in glycated hemoglobin A1C, while causing peripheral edema and weight gain. Rivoglitazone can be used in research related to type 2 diabetes .
loading...
    loading...
Cat. No.: HY-121900
CAS No.: 862901-87-9
Purity:  99.79%
Target:  

PPAR

Research Areas:  

Metabolic Disease Endocrinology

LT175, a dual PPARα/γ ligand, is an orally active partial agonist against PPARγ(hPPARα:EC50=0.22 μm; mPPARα:EC50=0.26 μm; hPPARγ:EC50=0.48 μm). LT175 interacts with PPARγ and affects the recruitment of the coregulators cyclic-AMP response element-binding protein-binding protein and nuclear corepressor 1 (NCoR1). LT175 interacts with PPARγ in a hydrophobic region called “diphenyl pocket”. LT175 has potent insulin-sensitizing effects and reduced adipogenic properties .
loading...
    loading...
Cat. No.: HY-146733
CAS No.: 3032632-02-0
Target:  

PPAR

Research Areas:  

Inflammation/Immunology

PPARα agonist 1 is a potent and full hPPARα agonist .
loading...
    loading...